ImmunityBio

ImmunityBio, formerly Etubics and NantCell, develops targeted immunotherapies and vaccine products for a wide range of resilient diseases.

Year Established: 2003 Stock Ticker: IBRX Exchange: NASDAQ

Locations

  • ImmunityBio

     Miramar FL

    ImmunityBio, formerly NantKwest, is a late-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancer and infectious disease.

  • ImmunityBio

     Louisville CO

    ImmunityBio, formerly NantKwest, is a late-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancer and infectious disease.

  • ImmunityBio

     El Segundo CA

    ImmunityBio, formerly NantKwest, is a late-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancer and infectious disease.

  • ImmunityBio

     Dunkirk NY

    ImmunityBio, formerly NantKwest, is a late-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancer and infectious disease.

  • ImmunityBio

     Culver City CA

    ImmunityBio, formerly NantKwest, is a late-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancer and infectious disease.

  • ImmunityBio

     San Diego CA

    ImmunityBio, formerly NantKwest, is a late-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancer and infectious disease.

  • ImmunityBio

     Woburn MA

    ImmunityBio, formerly NantKwest, is a late-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancer and infectious disease.

  • ImmunityBio

     Seattle WA

    ImmunityBio, formerly Etubics and NantCell, develops targeted immunotherapies and vaccine products for a wide range of resilient diseases.